These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28384687)

  • 21. Association of Attending Surgeon With Variation in the Receipt of Genetic Testing After Diagnosis of Breast Cancer.
    Katz SJ; Bondarenko I; Ward KC; Hamilton AS; Morrow M; Kurian AW; Hofer TP
    JAMA Surg; 2018 Oct; 153(10):909-916. PubMed ID: 29971344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
    Squires JE; Simard SN; Asad S; Stacey D; Graham ID; Coughlin M; Clemons M; Grimshaw JM; Zhang J; Caudrelier JM; Arnaout A
    Curr Oncol; 2019 Aug; 26(4):e439-e457. PubMed ID: 31548812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-Term Satisfaction and Body Image After Contralateral Prophylactic Mastectomy.
    Anderson C; Islam JY; Elizabeth Hodgson M; Sabatino SA; Rodriguez JL; Lee CN; Sandler DP; Nichols HB
    Ann Surg Oncol; 2017 Jun; 24(6):1499-1506. PubMed ID: 28058563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors associated with the increasing trend of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ: Analysis of Surveillance, Epidemiology, and End Results data.
    You Q; Chen K; Li Y; Lai J; Fang Y; Shen S; Liu Y; Su F; Yu F
    Breast; 2018 Aug; 40():147-155. PubMed ID: 29804045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State Variation in the Receipt of a Contralateral Prophylactic Mastectomy Among Women Who Received a Diagnosis of Invasive Unilateral Early-Stage Breast Cancer in the United States, 2004-2012.
    Nash R; Goodman M; Lin CC; Freedman RA; Dominici LS; Ward K; Jemal A
    JAMA Surg; 2017 Jul; 152(7):648-657. PubMed ID: 28355431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does it matter where you go for breast surgery?: attending surgeon's influence on variation in receipt of mastectomy for breast cancer.
    Katz SJ; Hawley ST; Abrahamse P; Morrow M; Friese CR; Alderman AK; Griggs JJ; Hamilton AS; Graff JJ; Hofer TP
    Med Care; 2010 Oct; 48(10):892-9. PubMed ID: 20808256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surgical Decision-Making Surrounding Contralateral Prophylactic Mastectomy: Comparison of Treatment Goals, Preferences, and Psychosocial Outcomes from a Multicenter Survey of Breast Cancer Patients.
    Lizarraga IM; Schroeder MC; Jatoi I; Sugg SL; Trentham-Dietz A; Hoeth L; Chrischilles EA
    Ann Surg Oncol; 2021 Dec; 28(13):8752-8765. PubMed ID: 34251554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
    Mamtani A; Sjoberg DD; Vincent A; Ehdaie B; Malhotra D; Vickers A; Morrow M
    Breast Cancer Res Treat; 2023 May; 199(1):119-126. PubMed ID: 36881270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer.
    Alderman AK; Hawley ST; Waljee J; Mujahid M; Morrow M; Katz SJ
    Cancer; 2008 Feb; 112(3):489-94. PubMed ID: 18157830
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision involvement and receipt of mastectomy among racially and ethnically diverse breast cancer patients.
    Hawley ST; Griggs JJ; Hamilton AS; Graff JJ; Janz NK; Morrow M; Jagsi R; Salem B; Katz SJ
    J Natl Cancer Inst; 2009 Oct; 101(19):1337-47. PubMed ID: 19720966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-Reported Outcomes After Choice for Contralateral Prophylactic Mastectomy.
    Hwang ES; Locklear TD; Rushing CN; Samsa G; Abernethy AP; Hyslop T; Atisha DM
    J Clin Oncol; 2016 May; 34(13):1518-27. PubMed ID: 26951322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decision making and factors influencing long-term satisfaction with prophylactic mastectomy in women with breast cancer.
    Soran A; Ibrahim A; Kanbour M; McGuire K; Balci FL; Polat AK; Thomas C; Bonaventura M; Ahrendt G; Johnson R
    Am J Clin Oncol; 2015 Apr; 38(2):179-83. PubMed ID: 23648435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
    Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of decision-making resources on satisfaction with decision to undergo contralateral prophylactic mastectomy (CPM).
    Huang J; Chagpar A
    Am J Surg; 2020 Jun; 219(6):1036-1038. PubMed ID: 31570198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.